Jolie's Decision Boosts BRCA Test-Maker Myriad
May 14, 2013 at 13:53 PM EDT
Shares of genetic test maker Myriad Genetics rose as much as 4 percent on Tuesday, after actress Angelina Jolie detailed her decision to undergo radical double-mastectomy, following testing which showed she carried a gene for breast cancer.
